Rearranged during Transfection (RET) Inhibitors [MoA] class drugs

3 results

  • gavreto - pralsetinib capsule

    (Pralsetinib)
    Genentech, Inc.
    GAVRETO is a kinase inhibitor for adults with metastatic RET fusion-positive non-small cell lung cancer, and for adults and patients 12+ with advanced or metastatic RET fusion-positive thyroid cancer requiring systemic therapy who are radioactive iodine-refractory.
    Medication Details
    Drug Interactions

  • retevmo - selpercatinib capsule

    (Selpercatinib)
    Eli Lilly And Company
    Retevmo treats adults with RET fusion-positive locally advanced or metastatic non-small cell lung cancer. It also treats adults and children (≥2 years) with RET-mutant or RET fusion-positive advanced thyroid cancers requiring systemic therapy, and RET fusion-positive solid tumors that progressed on prior treatment.
    Medication Details
    Drug Interactions